⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer

Official Title: A Pragmatic Cluster-Randomized Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer (AToM)

Study ID: NCT02485678

Study Description

Brief Summary: Comparison of the number of ER plus hospital visits that occurred during chemotherapy between the telephone intervention and control arms.

Detailed Description: Using a pragmatic cluster-randomized trial design, 20 Ontario cancer centres that provide care to patients with breast cancer will be randomly allocated to one of two arms: pro-active telephone toxicity management (intervention), or control (routine care). All patients with early stage (I-III) breast cancer who commence adjuvant or neo-adjuvant chemotherapy at participating institutions during the 6 to 12-month intervention period (will vary between centres depending on the number of incident cases) will be evaluated using Ontario healthcare administrative data. A sub-set of at least 25 patients at each participating institution will participate in a PRO sub-study involving the completion of standardized questionnaires to measure: a) severity of chemotherapy treatment toxicities; b) self-care for management of chemotherapy toxicities; c) self-efficacy (confidence) for managing symptoms; d) quality of life; and e) coordination of care. Patients participating in the PRO sub-study will be asked to provide consent to link their PRO data to Ontario healthcare administrative data so that correlations between the symptom self-assessments and Quality of Life (QoL) measures can be made with the administrative data on ED+H visits and use of supportive care medications. the investigators will compare the use of supportive care medications (i.e. anti-emetics, growth factors) by patients in the intervention and control arms to assess their influence on severity of chemotherapy-related toxicities as part of an exploratory sub-group analysis in patients \>65 years of age as administrative data on supportive care medication use is only available for this age group.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Royal Victoria Hospital, Barrie, Ontario, Canada

William Osler Health Centre, Brampton, Ontario, Canada

Juravinski Cancer Centre, Hamilton, Ontario, Canada

Cancer Centre of Southeastern Ontario at Kingston, Kingston, Ontario, Canada

Grand River Regional Cancer Centre, Kitchener, Ontario, Canada

London Regional Cancer Program, London, Ontario, Canada

Markham Stouffville, Markham, Ontario, Canada

Trillium Health Partners - The Credit Valley Hospital, Mississauga, Ontario, Canada

Southlake Regional Cancer Centre, Newmarket, Ontario, Canada

R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Ontario, Canada

The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada

Sault Area Hospital, Sault Ste. Marie, Ontario, Canada

Thunder Bay Regional Health Science Centre, Thunder Bay, Ontario, Canada

Rouge Valley Health System, Toronto, Ontario, Canada

Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, Ontario, Canada

St. Michael's Hospital, Toronto, Ontario, Canada

Mt. Sinai Hospital, Toronto, Ontario, Canada

Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Trillium Health Partners - Queensway Health Centre, Toronto, Ontario, Canada

Windsor Regional Cancer Centre, Windsor, Ontario, Canada

Contact Details

Name: Monika Krzyzanowska, MD

Affiliation: University Health Network - Princess Margaret Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: